Lauren Janulewicz, Ph.D. is an Associate at HCRx. Dr. Janulewicz primarily supports HCRx’s research efforts. Dr. Janulewicz also participates in HCRx’s business development and transaction-related activities, including financial analysis, transaction structuring, and due diligence. Dr. Janulewicz holds a Ph.D. in Molecular Biophysics from New York University, where she developed a life science tool used to discover druggable sites on an oncogene present in up to 20% of human cancer. Prior to that, Dr. Janulewicz received her M.Phil from NYU and a B.Sc. in Biochemistry and Molecular Biology from the University of Georgia.
This person is not in the org chart